Breaking News: Celestica’s Normal Course Issuer Bid Renewal Approved by TSX!

Celestica Inc. Terminates Existing Normal Course Issuer Bid and Launches New Bid Toronto, Oct. 30, 2024 (GLOBE NEWSWIRE) Celestica Inc. (NYSE: CLS) (TSX: CLS), a leader in design, manufacturing, hardware platform, and supply chain solutions for the world’s most innovative companies, made an announcement today regarding its normal course issuer bid. The company has terminated…

Read More

Trinity Capital Inc. Shares Exciting Third Quarter 2024 Financial Results: A Look into the Future

Trinity Capital Inc. Announces Record Third Quarter Financial Results Phoenix, Oct. 30, 2024 Trinity Capital Inc. (Nasdaq: TRIN), a leading provider of diversified financial solutions to growth-oriented companies, reported impressive financial results for the third quarter ended September 30, 2024. The company achieved a 16.2% Return on Average Equity (ROAE) with a record net investment…

Read More

Wingstop Inc. Announces Fiscal Q3 2024 Financial Results

Wingstop Inc. Delivers Record Third Quarter Results Setting the Standard for Growth and Profit Wingstop Inc., a leading restaurant chain specializing in chicken wings, has announced stellar financial results for the fiscal third quarter ended September 28, 2024. The company’s performance in Q3 2024 surpassed expectations, with impressive numbers across the board. Record-Breaking Performance During…

Read More

ProMIS Neurosciences: The Good, the Bad, and the Brainy – A Recap of PMN310’s Phase 1a Clinical Trial at the 17th Alzheimer’s Disease Conference

ProMIS Neurosciences: The Good, the Bad, and the Brainy – A Recap of PMN310’s Phase 1a Clinical Trial at the 17th Alzheimer’s Disease Conference Description: Results indicated PMN310 was generally well-tolerated and monthly dosing can provide CSF levels adequate for target engagement. Initiation of Phase 1b clinical trial in Alzheimer’s disease patients planned for year-end…

Read More

Breaking News: Director Discloses Personal Stock Ownership – You Won’t Believe What They’re Investing In!

Shell plc Announces Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities October 30, 2024 Details of Transactions: Shell plc (the “Company”) has disclosed that the following Persons Discharging Managerial Responsibilities (“PDMRs”) have received shares of the Company following the vesting of conditional awards granted on October 28, 2022 under the Shell Share…

Read More

Breaking News: Hope Therapeutics Inc. and NRX Pharmaceuticals Inc. (NASDAQ:NRXP) Join Forces to Acquire Florida’s First Interventional Psychiatry Clinics

Breaking News: Hope Therapeutics Inc. and NRX Pharmaceuticals Inc. (NASDAQ:NRXP) Join Forces to Acquire Florida’s First Interventional Psychiatry Clinics Description: The clinics are located in favorable locations, are revenue generating and EBITDA positive. Clinics offer a comprehensive range of mental health services. Acquisition is expected to be immediately accretive to revenue and EBITDA for HOPE…

Read More